Skip to content
10-K

Annual Report

ACTUATE THERAPEUTICS, INC. ACTU

0001683168-25-001581

← back to feed
Filed
Mar 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2024 · Mar 10, 2025 19.53M sh
Cash And Equivalents FY 2024 · Dec 31, 2024 $8.64M
Shares Diluted FY 2024 · Dec 31, 2023 1.43M sh
Operating Cash Flow FY 2024 · Dec 31, 2023 −$21.63M
Current Liabilities FY 2024 · Dec 31, 2023 $6.92M
Total Liabilities FY 2024 · Dec 31, 2023 $8.44M
Current Assets FY 2024 · Dec 31, 2023 $3M
Total Assets FY 2024 · Dec 31, 2023 $3M
Eps Diluted FY 2024 · Dec 31, 2023 −$17.24
Eps Basic FY 2024 · Dec 31, 2023 −$17.24
Sga Expense FY 2024 · Dec 31, 2023 $3.27M
Rd Expense FY 2024 · Dec 31, 2023 $21.71M
Net Income FY 2024 · Dec 31, 2023 −$24.74M
Operating Income FY 2024 · Dec 31, 2023 −$24.97M
Stockholders Equity FY 2024 · Dec 31, 2022 −$75.31M